110 related articles for article (PubMed ID: 1750800)
1. Transcriptional control mechanisms for the expression of type I collagen genes.
de Crombrugghe B; Vuorio T; Karsenty G; Maity S; Rutheshouser EC; Goldberg H
Ann Rheum Dis; 1991 Nov; 50 Suppl 4(Suppl 4):872-6. PubMed ID: 1750800
[No Abstract] [Full Text] [Related]
2. Control of type I collagen genes in scleroderma and normal fibroblasts.
de Crombrugghe B; Vuorio T; Karsenty G
Rheum Dis Clin North Am; 1990 Feb; 16(1):109-23. PubMed ID: 1689503
[TBL] [Abstract][Full Text] [Related]
3. Increased type I collagen mRNA levels in cultured scleroderma fibroblasts.
Kähäri VM; Vuorio T; Näntö-Salonen K; Vuorio E
Biochim Biophys Acta; 1984 Feb; 781(1-2):183-6. PubMed ID: 6696914
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma.
Eckes B; Mauch C; Hüppe G; Krieg T
Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):549-54. PubMed ID: 8615828
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M
Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
[TBL] [Abstract][Full Text] [Related]
6. Regulation of collagen gene expression by transformed human fibroblasts: decreased type I and type III collagen RNA transcription.
Hatamochi A; Ono M; Ueki H; Namba M
J Invest Dermatol; 1991 Apr; 96(4):473-7. PubMed ID: 1706744
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1.
Zhou B; Zhu H; Luo H; Gao S; Dai X; Li Y; Zuo X
Biomed Pharmacother; 2017 Mar; 87():412-418. PubMed ID: 28068631
[TBL] [Abstract][Full Text] [Related]
8. Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism.
McGaha TL; Kodera T; Spiera H; Stan AC; Pines M; Bona CA
Arthritis Rheum; 2002 Oct; 46(10):2748-61. PubMed ID: 12384935
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
10. Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts.
Yamane K; Ihn H; Kubo M; Tamaki K
Arthritis Rheum; 2002 Sep; 46(9):2421-8. PubMed ID: 12355490
[TBL] [Abstract][Full Text] [Related]
11. Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts.
Jimenez SA; Feldman G; Bashey RI; Bienkowski R; Rosenbloom J
Biochem J; 1986 Aug; 237(3):837-43. PubMed ID: 3800922
[TBL] [Abstract][Full Text] [Related]
12. Altered collagen and glycosaminoglycan syntheses in familial scleroderma skin fibroblasts.
Tajima S; Yamada H
Dermatology; 1995; 191(2):115-8. PubMed ID: 8520056
[TBL] [Abstract][Full Text] [Related]
13. Potential regulatory elements of the constitutive up-regulated alpha2(I) collagen gene in scleroderma dermal fibroblasts.
Jinnin M; Ihn H; Mimura Y; Asano Y; Tamaki K
Biochem Biophys Res Commun; 2006 May; 343(3):904-9. PubMed ID: 16564026
[TBL] [Abstract][Full Text] [Related]
14. alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma?
Kokot A; Sindrilaru A; Schiller M; Sunderkötter C; Kerkhoff C; Eckes B; Scharffetter-Kochanek K; Luger TA; Böhm M
Arthritis Rheum; 2009 Feb; 60(2):592-603. PubMed ID: 19180474
[TBL] [Abstract][Full Text] [Related]
15. Collagen gene expression.
Adams SL
Am J Respir Cell Mol Biol; 1989 Sep; 1(3):161-8. PubMed ID: 2696511
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of interleukin-4-induced up-regulation of type I collagen gene expression in murine fibroblasts.
McGaha TL; Le M; Kodera T; Stoica C; Zhu J; Paul WE; Bona CA
Arthritis Rheum; 2003 Aug; 48(8):2275-84. PubMed ID: 12905482
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype.
Kawakami T; Ihn H; Xu W; Smith E; LeRoy C; Trojanowska M
J Invest Dermatol; 1998 Jan; 110(1):47-51. PubMed ID: 9424086
[TBL] [Abstract][Full Text] [Related]
18. Role of protein kinase C-delta in the regulation of collagen gene expression in scleroderma fibroblasts.
Jimenez SA; Gaidarova S; Saitta B; Sandorfi N; Herrich DJ; Rosenbloom JC; Kucich U; Abrams WR; Rosenbloom J
J Clin Invest; 2001 Nov; 108(9):1395-403. PubMed ID: 11696585
[TBL] [Abstract][Full Text] [Related]
19. The protein phosphatase inhibitor okadaic acid suppresses type I collagen gene expression in cultured fibroblasts at the transcriptional level.
Westermarck J; Ilvonen E; Kähäri VM
Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):995-9. PubMed ID: 8948461
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1.
Shi-Wen X; Denton CP; Dashwood MR; Holmes AM; Bou-Gharios G; Pearson JD; Black CM; Abraham DJ
J Invest Dermatol; 2001 Mar; 116(3):417-25. PubMed ID: 11231316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
